These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8739396)

  • 21. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1996 Aug; 22(4):334-41. PubMed ID: 8875468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease.
    Finch CE; Marchalonis JJ
    Neurobiol Aging; 1996; 17(5):809-15. PubMed ID: 8892356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.
    Lue LF; Walker DG; Rogers J
    Neurobiol Aging; 2001; 22(6):945-56. PubMed ID: 11755003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease.
    Styren SD; Kamboh MI; DeKosky ST
    J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.
    Yi C; Mei X; Ezan P; Mato S; Matias I; Giaume C; Koulakoff A
    Cell Death Differ; 2016 Oct; 23(10):1691-701. PubMed ID: 27391799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of neuroinflammation in understanding Alzheimer's disease.
    Eikelenboom P; Veerhuis R; Scheper W; Rozemuller AJ; van Gool WA; Hoozemans JJ
    J Neural Transm (Vienna); 2006 Nov; 113(11):1685-95. PubMed ID: 17036175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
    Joachim CL; Morris JH; Selkoe DJ
    Am J Pathol; 1989 Aug; 135(2):309-19. PubMed ID: 2675616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
    Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
    Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease.
    Brandan E; Inestrosa NC
    Gen Pharmacol; 1993 Sep; 24(5):1063-8. PubMed ID: 8270163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.
    Cattaneo A; Cattane N; Galluzzi S; Provasi S; Lopizzo N; Festari C; Ferrari C; Guerra UP; Paghera B; Muscio C; Bianchetti A; Volta GD; Turla M; Cotelli MS; Gennuso M; Prelle A; Zanetti O; Lussignoli G; Mirabile D; Bellandi D; Gentile S; Belotti G; Villani D; Harach T; Bolmont T; Padovani A; Boccardi M; Frisoni GB;
    Neurobiol Aging; 2017 Jan; 49():60-68. PubMed ID: 27776263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.
    Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R
    Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals.
    Coria F; Moreno A; Rubio I; García MA; Morato E; Mayor F
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):261-8. PubMed ID: 8355812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease.
    Grammas P; Ovase R
    Neurobiol Aging; 2001; 22(6):837-42. PubMed ID: 11754990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease.
    Sokolova A; Hill MD; Rahimi F; Warden LA; Halliday GM; Shepherd CE
    Brain Pathol; 2009 Jul; 19(3):392-8. PubMed ID: 18637012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.
    Potter H; Wefes IM; Nilsson LN
    Neurobiol Aging; 2001; 22(6):923-30. PubMed ID: 11755000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.